CAR-T cell therapy

Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments with related expertise

Areas that research this procedure

Doctors who perform this procedure

Edit search filters
close

Narrow your search

  1. Find a doctor whose last name begins with the letter A
  2. Find a doctor whose last name begins with the letter B
  3. Find a doctor whose last name begins with the letter C
  4. Find a doctor whose last name begins with the letter D
  5. There are no doctors whose last name begins with the letter E
  6. There are no doctors whose last name begins with the letter F
  7. There are no doctors whose last name begins with the letter G
  8. Find a doctor whose last name begins with the letter H
  9. Find a doctor whose last name begins with the letter I
  10. There are no doctors whose last name begins with the letter J
  11. Find a doctor whose last name begins with the letter K
  12. There are no doctors whose last name begins with the letter L
  13. Find a doctor whose last name begins with the letter M
  14. There are no doctors whose last name begins with the letter N
  15. There are no doctors whose last name begins with the letter O
  16. There are no doctors whose last name begins with the letter P
  17. There are no doctors whose last name begins with the letter Q
  18. There are no doctors whose last name begins with the letter R
  19. There are no doctors whose last name begins with the letter S
  20. There are no doctors whose last name begins with the letter T
  21. There are no doctors whose last name begins with the letter U
  22. Find a doctor whose last name begins with the letter V
  23. There are no doctors whose last name begins with the letter W
  24. There are no doctors whose last name begins with the letter X
  25. There are no doctors whose last name begins with the letter Y
  26. There are no doctors whose last name begins with the letter Z
Reset all filters

Displaying 1-10 out of 19 doctors available

  1. Sikander Ailawadhi, M.D.

    Sikander Ailawadhi, M.D.

    1. Oncologist
    1. Jacksonville, FL
    Areas of focus:

    CAR-T cell therapy, Multiple myeloma, Leukemia, Chronic lymphocytic leukemia, Waldenstrom macroglobulinemia, Macroglobu...linemia, Chronic myelogenous leukemia, Plasma cell disorders

  2. Muhamad Alhaj Moustafa, M.D., M.S.

    Muhamad Alhaj Moustafa, M.D., M.S.

    1. Oncologist
    2. Hematologist
    1. Jacksonville, FL
    Areas of focus:

    Chemotherapy, Immunotherapy, Bone marrow biopsy and aspiration, CAR-T cell therapy, Cellular therapy, Lymphoma, Non-Hod...gkin's lymphoma, Hodgkin lymphoma, Hairy cell leukemia, Cutaneous t-cell lymphoma, Cutaneous b-cell lymphoma, Diffuse large b-cell lymphoma, Follicular lymphoma

  3. Hassan Alkhateeb, M.D.

    Hassan Alkhateeb, M.D.

    1. Hematologist
    1. Rochester, MN
    Areas of focus:

    CAR-T cell therapy, Autologous stem cell transplant, Allogeneic stem cell transplant, Acute lymphocytic leukemia, Acute... myelogenous leukemia, Myelodysplastic syndromes, Myeloproliferative disorders, Graft versus host disease

  4. Stephen M. Ansell, M.D., Ph.D.

    Stephen M. Ansell, M.D., Ph.D.

    1. Internist
    2. Oncologist
    3. Hematologist
    1. Rochester, MN
    Areas of focus:

    CAR-T cell therapy, Non-Hodgkin's lymphoma, Hodgkin lymphoma

  5. Steven Attia, D.O.

    Steven Attia, D.O.

    1. Oncologist
    1. Jacksonville, FL
    Areas of focus:

    CAR-T cell therapy, Bone cancer, Neurofibromatosis, Rhabdomyosarcoma, Chordoma, Soft tissue sarcoma, Gastrointestinal s...tromal tumor, Desmoid tumor, Giant cell tumor, Benign bone tumor, Pigmented villonodular synovitis

  6. Ernesto Ayala, M.D.

    Ernesto Ayala, M.D.

    1. Jacksonville, FL
    Areas of focus:

    CAR-T cell therapy, Bone marrow transplant, Autologous stem cell transplant, Allogeneic stem cell transplant, Acute lym...phocytic leukemia, Acute myelogenous leukemia, Non-Hodgkin's lymphoma, Hodgkin lymphoma, Graft versus host disease

  7. N. Nora Bennani, M.D.

    N. Nora Bennani, M.D.

    1. Internist
    2. Oncologist
    3. Hematologist
    1. Rochester, MN
    Areas of focus:

    CAR-T cell therapy, Lymphoma, Cutaneous t-cell lymphoma

  8. Matthew S. Block, M.D., Ph.D.

    Matthew S. Block, M.D., Ph.D.

    1. Oncologist
    1. Rochester, MN
    Areas of focus:

    CAR-T cell therapy, Biological therapy for cancer, Melanoma, Gynecologic cancer

  9. Januario E. Castro, M.D.

    Januario E. Castro, M.D.

    1. Hematologist / Oncologist
    Areas of focus:

    CAR-T cell therapy, Lymphoma, Chronic lymphocytic leukemia

  10. Urshila Durani, M.D., M.P.H.

    Urshila Durani, M.D., M.P.H.

    1. Internist
    2. Oncologist
    3. Hematologist
    1. Rochester, MN
    Areas of focus:

    CAR-T cell therapy, Bone marrow transplant, Non-Hodgkin's lymphoma, Hodgkin lymphoma

Research

Doctors and researchers at Mayo Clinic are studying ways to improve treatment options for blood cancers, including CAR-T cell therapy and other innovations in cancer treatment.

Blood cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Publications

See a list of publications about CAR-T cell therapy by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

By Mayo Clinic Staff

CAR-T cell therapy care at Mayo Clinic

AboutCare at Mayo Clinic
June 27, 2025
Print
  1. Brudno JN, et al. CAR T cells and T-cell therapies for cancer. JAMA. 2024; doi:10.1001/jama.2024.19462.
  2. CAR T cells: Engineering patients' immune cells to treat their cancers. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. Accessed April 16, 2025.
  3. Kymriah (prescribing information). Novartis; 2024. https://us.kymriah.com. Accessed April 24, 2025.
  4. Yescarta (prescribing information). Kite Pharma; 2024. https://www.yescartahcp.com. Accessed April 24, 2025.
  5. Tecartus (prescribing information). Kite Pharma; 2024. https://www.tecartushcp.com. Accessed April 24, 2025.
  6. Breyanzi (prescribing information). Bristol Myers Squibb; 2024. https://www.breyanzihcp.com. Accessed April 24, 2025.
  7. Abecma (prescribing information). Bristol Myers Squibb; 2024. https://www.abecma.com/. Accessed April 24, 2025.
  8. Carvykti (prescribing information). Janssen Biotech; 2024. https://www.carvykti.com. Accessed April 24, 2025.
  9. Aucatzyl (prescribing information). Autolus; 2024. https://www.autolus.com. Accessed April 24, 2025.
  10. Roddie C, et al. Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia. New England Journal of Medicine. 2024; doi:10.1056/NEJMoa2406526.
  11. Immunotherapy side effects: CAR T-cell therapy. National Comprehensive Cancer Network. http://www.NCCN.org/patientguidelines. Accessed April 16, 2025.
  12. Hines MR, et al. Immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome. Transplantation and Cellular Therapy. 2023; doi:10.1016/j.jtct.2023.03.006.
  13. Amini L, et al. Preparing for CAR T cell therapy: Patient selection, bridging therapies and lymphodepletion. Nature Reviews: Clinical Oncology. 2022; doi:10.1038/ s41571-022-00607-3.
  14. Steinbach M, et al. Nursing care throughout the chimeric antigen receptor T-cell therapy process for multiple myeloma. Seminars in Oncology Nursing. 2023; doi:10.1016/j.soncn.2023.151505.
  15. Acute lymphoblastic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1410. Accessed April 22, 2025.
  16. B-cell lymphomas. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1480. Accessed April 22, 2025.
  17. Chronic lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1478. Accessed April 22, 2025.
  18. Multiple myeloma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1445. Accessed April 22, 2025.
  19. Shoushtari AN, et al. Principles of cancer immunotherapy. https://www.uptodate.com/contents/search. Accessed April 21, 2025.
  20. T-cell transfer therapy. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy. Accessed April 24, 2025.
  21. Health Education & Content Services. Chimeric antigen receptor T-cell (CAR-T) therapy. Mayo Clinic; 2019.
  22. Bashir Q, et al., eds. Process and general management of patients undergoing chimeric antigen receptor therapies. In: Manual of Hematopoietic Cell Transplantation and Cellular Therapies. Elsevier; 2024. https://www.clinicalkey.com. Accessed May 1, 2025.
  23. Neelapu SS, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. New England Journal of Medicine. 2017; doi:10.1056/NEJMoa1707447.

Related

News from Mayo Clinic

Products & Services

CAR-T cell therapy